M U13 (Bupropion Extended Release (SR) 200 mg)
Pill imprint M U13 has been identified as Bupropion hydrochloride extended release (SR) 200 mg.
Bupropion is used in the treatment of sexual dysfunction, ssri induced; major depressive disorder; depression; obesity; adhd (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M U13
- Strength:
- 200 mg
- Color:
- Green
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antidepressants
Smoking cessation agents - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3413
- Inactive Ingredients:
- silicon dioxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 40
hydrochloric acid
hydroxypropyl cellulose (type h)
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
stearic acid
titanium dioxide
triacetin
More about bupropion
Consumer resources
- Bupropion
- Bupropion extended-release tablets
- Bupropion hydrobromide extended-release tablets
- Bupropion sustained-release tablets
- Bupropion (Advanced Reading)
- Other brands: Wellbutrin, Wellbutrin XL, Wellbutrin SR, Zyban, More (5) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
